Medidata Reports Fourth Quarter 2018 Results

Go back to Medidata Reports Fourth Quarter 2018 Results

Needham & Company Reiterates Hold on Medidata Solutions (MDSO) Following 4Q

February 13, 2019 9:19 AM EST

Needham & Company analyst, Scott Berg, reiterated a Hold rating on Medidata Solutions (NASDAQ: MDSO) following the company's 4Q earnings report. 4Q revenue was ahead of consensus but the EPS outperformance was driven by a lower than guided tax rate.

Initial 2019 guidance is below... More

Jefferies Remains Sidelined on Medidata Solutions (MDSO)

February 13, 2019 9:16 AM EST

Jefferies analyst, David Windley, reiterated a Hold rating and $76.00 price target on Medidata Solutions (NASDAQ: MDSO) following the company's 4Q report. MDSO had met or exceeded estimates through 3Q, but lost momentum in 4Q, slightly missing on revs & EBITDA. EBITDA margin for FY18... More

Medidata Solutions (MDSO) Tops Q4 EPS by 8c, Offers FY Guidance

February 12, 2019 6:32 AM EST

Medidata Solutions (NASDAQ: MDSO) reported Q4 EPS of $0.45, $0.08 better than the analyst estimate of $0.37. Revenue for the quarter came in at $167.2 million versus the consensus estimate of $167.92 million.

GUIDANCE:

Medidata Solutions sees FY2019 revenue of $734-746 million, versus the consensus of $749.49... More